Manufacturing

Ben Wylie is head of Product Management and Marketing at ChargePoint Technologies.

Articles

Single-use technologies provide a barrier between operators and drug products, allowing for sterility and personnel safety in manufacturing.

De-Risking Sterile Pharma Manufacture with SUTs

Matthew Hewitt is vice-president, technical officer, Cell & Gene Therapy & Biologics at Charles River Laboratories.

Larry Bellot, PhD, is scientific advisor, Cell and Gene Therapy, at Charles River Laboratories.

Chad Andersen is associate director, Manufacturing Sciences & Technology, at Charles River Laboratories.

A look at using best practice tech transfer methods for CGTs to increase process and analytics robustness while being scalable.

Best Practice Tech Transfer Methods for CGTs

This agreement is intended to be executed and see the impact of any financial transfers by the fiscal year ending March 31, 2024.

Astellas Pharma to Transfer Manufacturing Plant, Business to Delpharm 

Forge will provide adeno-associated virus (AAV) process development, toxicology, cGMP manufacturing, and analytical services to Life Bio, which will occur at Forge’s gene therapy facility in Columbus, Ohio called the Hearth.

Life Biosciences, Forge Biologics Partner for Manufacturing to Advance Gene Therapies

The new agreement is based off the Master Services Agreement that both companies entered in 2021 for the development, manufacture, and supply of rhenium (186Re) obisbemeda, according to a press release.

Plus Therapeutics Expands Collaboration with Piramal Pharma Solutions 

Editor of Pharmaceutical Technology Europe

Alternative approaches to freeze drying are gaining popularity and will help to overcome some of the challenges associated with conventional lyophilization.

Accepting Alternative Approaches to Freeze Drying

Christian Goesker is managing director of CRB Group.

Thomas Lederer is office lead, director EPCM Projects, CRB Group.

Mike Barrett is vice president, Project Delivery Services, CRB Group.

By eliminating the waste involved in traditional approaches to project set-up and execution, integrated project delivery helps innovators in the European life sciences market meet their fast-track delivery targets.

How Integrated Project Delivery Enables Speed: A Phase-By-Phase Guide 

Agnes Shanley is senior editor of Pharmaceutical Technology.

Better understanding and control of cell behavior is yielding benefits, upstream and beyond. 


Improving Upstream Predictability

Accelerated approval pathways and growing demand for cell and gene therapies are putting pressure on providers of cellular starting materials, and they must ensure a steady supply.

The Evolving Role of Starting Materials in Cell and Gene Therapy

Feliza Mirasol is the science editor for 

Connectors are a critical element in the process optimization of single-use bioprocessing systems.

Manufacturing Best Practices